[Retracted] Integrative Nomogram of Computed Tomography Radiomics, Clinical, and Tumor Immune Features for Analysis of Disease-Free Survival of NSCLC Patients with Surgery

Figure 3

Immunophenotyping by tumor immune microenvironment (TIME) indicated by PD-L1 and CD8 TILs. The thumbnail indicates where the image was located, so actually strong tumor area may be excluded. (I): type (I) adaptive immune resistance (PD-L1 positive and high CD8 TILs). II: type II, immune ignorance (PD-L1 negative and low CD8 TILs). III: type III, intrinsic induction (PD-L1 positive and low CD8 TILs), IV: type IV, immune tolerance (PD-L1 negative and high CD8 TILs).